Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet - PubMed (original) (raw)

Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet

Howard G Shertzer et al. J Nutr. 2011.

Abstract

Consuming a high-fat (HF) diet produces excessive weight gain, adiposity, and metabolic complications associated with risk for developing type 2 diabetes and fatty liver disease. This study evaluated the influence of whey protein isolate (WPI) on systemic energy balance and metabolic changes in mice fed a HF diet. Female C57BL/6J mice received for 11 wk a HF diet, with or without 100 g WPI/L drinking water. Energy consumption and glucose and lipid metabolism were examined. WPI mice had lower rates of body weight gain and percent body fat and greater lean body mass, although energy consumption was unchanged. These results were consistent with WPI mice having higher basal metabolic rates, respiratory quotients, and hepatic mitochondrial respiration. Health implications for WPI were reflected in early biomarkers for fatty liver disease and type 2 diabetes. Livers from WPI mice had significantly fewer hepatic lipid droplet numbers and less deposition of nonpolar lipids. Furthermore, WPI improved glucose tolerance and insulin sensitivity. We conclude that in mice receiving a HF diet, consumption of WPI results in higher basal metabolic rates and altered metabolism of dietary lipids. Because WPI mice had less hepatosteatosis and insulin resistance, WPI dietary supplements may be effective in slowing the development of fatty liver disease and type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: H. G. Shertzer, S. E. Woods, M. Krishan, M. B. Genter, and K. J. Pearson, no conflicts of interest.

Figures

FIGURE 1

FIGURE 1

Cumulative percent increases in body weight (BW) in HF and WPI mice. Initial body weights for HF and WPI mice were 23.4 ± 0.9 g and 24 ± 1.1 g, respectively. Values are means ± SEM, n = 4.

FIGURE 2

FIGURE 2

Glucose tolerance in HF and WPI mice. Blood glucose was determined after 8-h feed deprivation. Following i.p. glucose administration, blood glucose concentrations were measured at intervals. The insert shows the calculated area-under-the-curve (AUC) value for each line. Values are means ± SEM, n = 4.

References

    1. Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271–81 - PMC - PubMed
    1. Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010;13:397–402 - PubMed
    1. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr. 2010;46:212–23 - PMC - PubMed
    1. Shertzer HG, Schneider SN, Kendig EL, Clegg DJ, D'Alessio DA, Genter MB. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem Pharmacol. 2008;75:1402–10 - PubMed
    1. Kendig EL, Schneider SN, Clegg DJ, Genter MB, Shertzer HG. Over-the-counter analgesics normalize blood glucose and body composition in mice fed a high fat diet. Biochem Pharmacol. 2008;76:216–24 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources